Kendall Capital Management Bristol Myers Squibb CO Transaction History

Kendall Capital Management

$316 Million
Q3 2024

A detailed history of Kendall Capital Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Kendall Capital Management holds 44,647 shares of BMY stock, worth $2.51 Million. This represents 0.73% of its overall portfolio holdings.

Number of Shares

44,647

Previous 46,942 4.89%

Holding current value

$2.51 Million

Previous $1.95 Million 18.52%

% of portfolio

0.73%

Previous 0.66%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$39.66 - $51.75 $91,019 - $118,766	-2,295 Reduced 4.89%	44,647 $2.31 Million
Q2 2024 Aug 12, 2024	SELL	$40.25 - $52.99 $62,065 - $81,710	-1,542 Reduced 3.18%	46,942 $1.95 Million
Q1 2024 May 10, 2024	BUY	$47.98 - $54.4 $83,629 - $94,819	1,743 Added 3.73%	48,484 $2.63 Million
Q4 2023 Jan 26, 2024	BUY	$48.48 - $57.85 $29,572 - $35,288	610 Added 1.32%	46,741 $2.4 Million
Q3 2023 Oct 31, 2023	BUY	$57.89 - $64.73 $59,163 - $66,154	1,022 Added 2.27%	46,131 $2.68 Million
Q2 2023 Jul 28, 2023	BUY	$63.71 - $70.74 $17,520 - $19,453	275 Added 0.61%	45,109 $2.89 Million
Q1 2023 May 11, 2023	BUY	$65.71 - $74.53 $70,046 - $79,448	1,066 Added 2.44%	44,834 $3.11 Million
Q4 2022 Jan 30, 2023	SELL	$68.48 - $81.09 $121,278 - $143,610	-1,771 Reduced 3.89%	43,768 $3.15 Million
Q3 2022 Nov 02, 2022	BUY	$0.13 - $76.84 $161 - $95,281	1,240 Added 2.8%	45,539 $3.24 Million
Q2 2022 Jul 29, 2022	SELL	$72.62 - $79.98 $31,226 - $34,391	-430 Reduced 0.96%	44,299 $3.41 Million
Q1 2022 May 06, 2022	BUY	$61.48 - $73.72 $142,326 - $170,661	2,315 Added 5.46%	44,729 $3.27 Million
Q4 2021 Jan 28, 2022	BUY	$53.63 - $62.52 $186,203 - $217,069	3,472 Added 8.92%	42,414 $2.65 Million
Q3 2021 Nov 05, 2021	BUY	$59.17 - $69.31 $348,807 - $408,582	5,895 Added 17.84%	38,942 $2.3 Million
Q2 2021 Jul 30, 2021	BUY	$61.91 - $67.42 $172,109 - $187,427	2,780 Added 9.18%	33,047 $2.21 Million
Q1 2021 May 05, 2021	BUY	$59.34 - $66.74 $257,238 - $289,317	4,335 Added 16.72%	30,267 $1.91 Million
Q4 2020 Feb 08, 2021	BUY	$57.74 - $65.43 $133,956 - $151,797	2,320 Added 9.83%	25,932 $1.61 Million
Q3 2020 Oct 22, 2020	BUY	$57.43 - $63.64 $53,409 - $59,185	930 Added 4.1%	23,612 $1.42 Million
Q2 2020 Jul 30, 2020	BUY	$54.82 - $64.09 $316,969 - $370,568	5,782 Added 34.21%	22,682 $1.33 Million
Q1 2020 Apr 27, 2020	SELL	$46.4 - $67.43 $145,000 - $210,718	-3,125 Reduced 15.61%	16,900 $942,000
Q4 2019 Jan 24, 2020	BUY	$49.21 - $64.19 $106,785 - $139,292	2,170 Added 12.15%	20,025 $1.29 Million
Q3 2019 Nov 12, 2019	BUY	$42.77 - $50.71 $111,415 - $132,099	2,605 Added 17.08%	17,855 $905,000
Q2 2019 Aug 09, 2019	BUY	$44.62 - $49.34 $101,956 - $112,741	2,285 Added 17.62%	15,250 $692,000
Q1 2019 May 08, 2019	BUY	$45.12 - $53.8 $208,905 - $249,094	4,630 Added 55.55%	12,965 $619,000
Q4 2018 Feb 13, 2019	BUY	$48.76 - $63.23 $123,606 - $160,288	2,535 Added 43.71%	8,335 $433,000
Q3 2018 Oct 29, 2018	BUY	$55.19 - $62.25 $320,102 - $361,050	5,800 New	5,800 $360,000

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kendall Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Kendall Capital Management with notifications on news.

Account

Kendall Capital Management Bristol Myers Squibb CO Transaction History